NCT05460715Active, not recruiting
The Medacta Quadra-P Anteverted Study
Prospective Multicentre Study to Evaluate the Long-term Performance of Anteverted Femoral Stems in Total Hip Arthroplasty
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
This is a Post-Marketing Surveillance of Quadra-P anteverted stem prosthesis.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 12 Jul 2022
- Start date
- 30 Jul 2021
- Primary completion date
- Jul 2032
- Lead sponsor
- Medacta International SA
- Diseases
- Rheumatoid arthritis
- NCT number
- NCT05460715
What you commit to
- Study type: Observational
- Planned participants: 300
- From 30 Jul 2021 to the primary completion date, Jul 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subjects with acute or chronic infection
- Subjects with mental conditions that impair their ability to consent to the study, to complete required questionnaires or to complete follow-up visits
- Subjects with metabolic disorders that may involve bone metabolism for which an uncemented implant would be contraindicated
- Subjects with muscular atrophy or neuromuscular diseases
- Subjects allergic to the materials used during surgery
- Any other condition not mentioned in the inclusion criteria
Other
- Subjects with a femoral neck fracture
- Subjects with severe deformities, at the discretion of the surgeon
- Subjects unable or unwilling to provide consent for participation in the study
Who the study is looking for
- Subjects suffering from primary hip arthrosis, post-traumatic arthrosis, dysplasia or avascular necrosis of the femoral head, rheumatoid arthritis
- Adult subjects between 18 and 75 years of age on the date of surgery
- Subjects eligible for primary total hip arthroplasty surgery for whom the anterior Quadra-P femoral component will be implanted according to the indications for use of the implant
- Subjects who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to surgery.
- For the anatomical-functional subgroup:
- \- Adult subjects aged between 18 and 65 years at the date of surgery who have agreed to undergo the gait analysis study.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istituto Ortopedico Franco Scalabrino Coordinator of this site? Confirm its status | Messina | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.